The downregulation of another pair of oncogenes in DLBCL, FBN1, and TIMP1 resulted in the downregulation of Wnt3, GSK3β, β-catenin, c-Myc, and cyclin D1, suggesting the inactivation of Wnt/β-catenin signaling [45]. The gene discussed is GSK3B; the disease is diffuse large B-cell lymphoma.